Corient Private Wealth LLC Sells 20,865 Shares of Lam Research Corporation $LRCX

Corient Private Wealth LLC lowered its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 1.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,823,595 shares of the semiconductor company’s stock after selling 20,865 shares during the quarter. Corient Private Wealth LLC owned about 0.14% of Lam Research worth $177,511,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently bought and sold shares of LRCX. IMG Wealth Management Inc. acquired a new position in Lam Research during the second quarter valued at approximately $26,000. Howard Hughes Medical Institute bought a new stake in shares of Lam Research during the 2nd quarter worth $27,000. Strategic Wealth Investment Group LLC acquired a new position in Lam Research in the 2nd quarter valued at $29,000. Delos Wealth Advisors LLC bought a new position in Lam Research in the 2nd quarter worth $30,000. Finally, REAP Financial Group LLC acquired a new position in Lam Research during the 2nd quarter worth $31,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Price Performance

Shares of LRCX stock opened at $160.52 on Monday. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $169.69. The company has a market capitalization of $201.62 billion, a P/E ratio of 35.36, a P/E/G ratio of 1.65 and a beta of 1.77. The stock has a 50 day moving average of $152.53 and a two-hundred day moving average of $120.50. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same period in the prior year, the company posted $0.86 earnings per share. Lam Research’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a yield of 0.6%. Lam Research’s payout ratio is presently 22.91%.

Insider Buying and Selling at Lam Research

In other news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on LRCX shares. Evercore ISI raised their price target on Lam Research from $115.00 to $170.00 and gave the company an “outperform” rating in a research report on Thursday, October 23rd. Dbs Bank increased their target price on Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. Cowen reaffirmed a “buy” rating on shares of Lam Research in a report on Thursday, October 23rd. Needham & Company LLC lifted their price target on Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Finally, Barclays set a $142.00 price objective on Lam Research and gave the company an “equal weight” rating in a research report on Monday, October 20th. Twenty-six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $152.87.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.